{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:57Z","timestamp":1781636097271,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Given the pivotal roles of miRNAs as regulators of gene expression, circulating miRNAs offer promising non-invasive diagnostic and therapeutic avenues. The evolving landscape of SARS-CoV-2 variants poses challenges for traditional disease detection and control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To unveil the specific circulating miRNA profiles linked to COVID-19 and its correlation with severity levels, qPCR was conducted on five potential miRNAs in plasma samples obtained from 112 COVID-19 patients (comprising 58 severe, 50 moderate, and four mild cases) upon hospital admission during two waves (Beta and Delta variants) of the pandemic, alongside samples from 112 healthy controls. Moreover, correlations between miRNA expression and various clinical laboratory parameters were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two miRNAs, including miR-19a-3p and miR-374b-5p, were upregulated, and two were downregulated (miR-15b-5p and miR-320a-5p), while the miR-423-5p expression was not changed in COVID-19 patients. ROC curve analysis demonstrated that miR-15b-5p and miR-320a-5p showed the highest specificity and sensitivity. In addition, significant correlations were found between miRNA expression and various laboratory parameters, suggesting that these miRNAs may serve as potential biomarkers for disease severity and progression. Further analysis during different COVID-19 waves and severity levels revealed consistent miRNA expression patterns among the two waves of infection, and most importantly, significant changes in expression among the mild\/moderate versus severe infected patients, underscoring their diagnostic value upon different virus strain infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While miRNAs do not replace RT-PCR for viral detection, they offer valuable diagnostic insights into host response and disease dynamics, and may enhance early screening, risk stratification, and monitoring in clinical settings. This study highlights the role of miRNAs as non-invasive biomarkers for the diagnosis and monitoring of COVID-19. In conclusion, the SARS-CoV-2 virus is constantly evolving and mutating. The data presented here explores the distinct role of circulating miRNAs within individuals affected by different variants of COVID-19, unveiling their promise as non-invasive diagnostic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12706-y","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:09:54Z","timestamp":1771229394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host MiRNA responses during different waves of SARS-CoV-2: diagnostic implications of miR-19a-3p, miR-374b-5p, miR-15b-5p, and miR-320a-5p expression"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2592-836X","authenticated-orcid":false,"given":"Esraa S.","family":"AL-Aasar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda Y.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S. Abu","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7608-850X","authenticated-orcid":false,"given":"Khaled M.","family":"Aboshanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-6074","authenticated-orcid":false,"given":"Mohamed A.","family":"Tantawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"12706_CR1","unstructured":"WHO COVID-19 cases. WHO COVID-19 cases. 2025. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c. Accessed 20 Nov 2025."},{"key":"12706_CR2","unstructured":"WHO. COVID-19 deaths. COVID-19 deaths. 2025. https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c. Accessed 20 Nov 2025."},{"key":"12706_CR3","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R, Features. Evaluation, and treatment of coronavirus (COVID-19). Treasure Island (FL). StatPearls Publishing, USA; 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/32150360\/. Accessed 20 Nov 2025."},{"key":"12706_CR4","doi-asserted-by":"publisher","first-page":"109040","DOI":"10.1016\/j.intimp.2022.109040","volume":"110","author":"SS Mortazavi-Jahromi","year":"2022","unstructured":"Mortazavi-Jahromi SS, Aslani M. Dysregulated MiRNAs network in the critical COVID-19: an important clue for uncontrolled immunothrombosis\/thromboinflammation. Int Immunopharmacol. 2022;110:109040. https:\/\/doi.org\/10.1016\/j.intimp.2022.109040.","journal-title":"Int Immunopharmacol"},{"key":"12706_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.omtn.2022.07.007","volume":"29","author":"N Ghosh","year":"2022","unstructured":"Ghosh N, Fenton S, van Hout I, Jones GT, Coffey S, Williams MJA, et al. Therapeutic knockdown of miR-320 improves deteriorated cardiac function in a pre-clinical model of non-ischemic diabetic heart disease. Mol Ther Nucleic Acids. 2022;29:330\u201342. https:\/\/doi.org\/10.1016\/j.omtn.2022.07.007.","journal-title":"Mol Ther Nucleic Acids"},{"key":"12706_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrg1328","volume":"5","author":"DP Bartel","year":"2004","unstructured":"Bartel DP, Chen C-Z. Micromanagers of gene expression: the potentially widespread influence of metazoan MicroRNAs. Nat Rev Genet. 2004;5:396\u2013400. https:\/\/doi.org\/10.1038\/nrg1328.","journal-title":"Nat Rev Genet"},{"key":"12706_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP, MicroRNAs. Target recognition and regulatory functions. Cell. 2009;136:215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"12706_CR8","doi-asserted-by":"publisher","unstructured":"Sharma G, Agarwal D, Bhadada SK. Influence of MicroRNAs on clinical alliance of COVID-19 and diabetes. MicroRNA in human infectious diseases. Elsevier; 2024. 165\u201377. https:\/\/doi.org\/10.1016\/B978-0-323-99661-7.00006-0.","DOI":"10.1016\/B978-0-323-99661-7.00006-0"},{"key":"12706_CR9","doi-asserted-by":"publisher","first-page":"e9994","DOI":"10.7717\/peerj.9994","volume":"8","author":"S Nersisyan","year":"2020","unstructured":"Nersisyan S, Engibaryan N, Gorbonos A, Kirdey K, Makhonin A, Tonevitsky A. Potential role of cellular MiRNAs in coronavirus-host interplay. PeerJ. 2020;8:e9994. https:\/\/doi.org\/10.7717\/peerj.9994.","journal-title":"PeerJ"},{"key":"12706_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.tig.2007.02.011","volume":"23","author":"TW Nilsen","year":"2007","unstructured":"Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet. 2007;23:243\u20139. https:\/\/doi.org\/10.1016\/j.tig.2007.02.011.","journal-title":"Trends Genet"},{"key":"12706_CR11","doi-asserted-by":"publisher","unstructured":"Ghosal S, Das S, Sen R, Chakrabarti J. HumanViCe: host CeRNA network in virus infected cells in human. Front Genet. 2014;5. https:\/\/doi.org\/10.3389\/fgene.2014.00249.","DOI":"10.3389\/fgene.2014.00249"},{"key":"12706_CR12","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.2147\/IJGM.S335162","volume":"14","author":"M Qi","year":"2021","unstructured":"Qi M, Liu B, Li S, Ni Z, Li F. Construction and investigation of competing endogenous RNA networks and candidate genes involved in SARS-CoV-2 infection. Int J Gen Med. 2021;14:6647\u201359. https:\/\/doi.org\/10.2147\/IJGM.S335162.","journal-title":"Int J Gen Med"},{"key":"12706_CR13","doi-asserted-by":"publisher","first-page":"105613","DOI":"10.1016\/j.meegid.2024.105613","volume":"122","author":"M Aghajani Mir","year":"2024","unstructured":"Aghajani Mir M. Illuminating the pathogenic role of SARS-CoV-2: insights into competing endogenous RNAs (ceRNAs) regulatory networks. Infect Genet Evol. 2024;122:105613. https:\/\/doi.org\/10.1016\/j.meegid.2024.105613.","journal-title":"Infect Genet Evol"},{"key":"12706_CR14","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.3390\/ijms21134807","volume":"21","author":"SMA Hosseini Rad","year":"2020","unstructured":"Hosseini Rad SMA, McLellan AD. Implications of SARS-CoV-2 mutations for genomic RNA structure and host MicroRNA targeting. Int J Mol Sci. 2020;21:4807. https:\/\/doi.org\/10.3390\/ijms21134807.","journal-title":"Int J Mol Sci"},{"key":"12706_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.trsl.2021.05.004","volume":"236","author":"ID de GONZALO-CALVO D, BEN\u00cdTEZ","year":"2021","unstructured":"de GONZALO-CALVO D, BEN\u00cdTEZ ID, CARRATAL\u00c1 A PINILLAL, MONCUS\u00cd-MOIX A, GORT-PANIELLO C, et al. Circulating MicroRNA profiles predict the severity of COVID-19 in hospitalized patients. Translational Res. 2021;236:147\u201359. https:\/\/doi.org\/10.1016\/j.trsl.2021.05.004.","journal-title":"Translational Res"},{"key":"12706_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cvr\/cvab338","volume":"118","author":"C Gutmann","year":"2022","unstructured":"Gutmann C, Khamina K, Theofilatos K, Diendorfer AB, Burnap SA, Nabeebaccus A, et al. Association of cardiometabolic MicroRNAs with COVID-19 severity and mortality. Cardiovasc Res. 2022;118:461\u201374. https:\/\/doi.org\/10.1093\/cvr\/cvab338.","journal-title":"Cardiovasc Res"},{"key":"12706_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/vaccines9101056","volume":"9","author":"A Parray","year":"2021","unstructured":"Parray A, Mir FA, Doudin A, Iskandarani A, Danjuma IMM, Kuni RAT, et al. SnoRNAs and MiRNAs networks underlying COVID-19 disease severity. Vaccines (Basel). 2021;9:1056. https:\/\/doi.org\/10.3390\/vaccines9101056.","journal-title":"Vaccines (Basel)"},{"key":"12706_CR18","doi-asserted-by":"publisher","first-page":"111636","DOI":"10.1016\/j.mad.2022.111636","volume":"202","author":"A Giuliani","year":"2022","unstructured":"Giuliani A, Matacchione G, Ramini D, Di Rosa M, Bonfigli AR, Sabbatinelli J, et al. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality. Mech Ageing Dev. 2022;202:111636. https:\/\/doi.org\/10.1016\/j.mad.2022.111636.","journal-title":"Mech Ageing Dev"},{"key":"12706_CR19","doi-asserted-by":"publisher","first-page":"104832","DOI":"10.1016\/j.meegid.2021.104832","volume":"91","author":"R Marchi","year":"2021","unstructured":"Marchi R, Sugita B, Centa A, Fonseca AS, Bortoletto S, Fiorentin K, et al. The role of MicroRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review. Infect Genet Evol. 2021;91:104832. https:\/\/doi.org\/10.1016\/j.meegid.2021.104832.","journal-title":"Infect Genet Evol"},{"key":"12706_CR20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.7150\/ijms.76168","volume":"19","author":"C-Y Yang","year":"2022","unstructured":"Yang C-Y, Chen Y-H, Liu P-J, Hu W-C, Lu K-C, Tsai K-W. The emerging role of MiRNAs in the pathogenesis of COVID-19: protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection. Int J Med Sci. 2022;19:1340\u201356. https:\/\/doi.org\/10.7150\/ijms.76168.","journal-title":"Int J Med Sci"},{"key":"12706_CR21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/biomedicines8110462","volume":"8","author":"A Matarese","year":"2020","unstructured":"Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines. 2020;8:462. https:\/\/doi.org\/10.3390\/biomedicines8110462.","journal-title":"Biomedicines"},{"key":"12706_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yjmcc.2020.08.017","volume":"148","author":"D Lu","year":"2020","unstructured":"Lu D, Chatterjee S, Xiao K, Riedel I, Wang Y, Foo R, et al. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J Mol Cell Cardiol. 2020;148:46\u20139. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.08.017.","journal-title":"J Mol Cell Cardiol"},{"key":"12706_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ncrna.2020.08.002","volume":"5","author":"H Haddad","year":"2020","unstructured":"Haddad H, Walid Al-Zyoud. MiRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, middle East. Noncoding RNA Res. 2020;5:135\u201343. https:\/\/doi.org\/10.1016\/j.ncrna.2020.08.002.","journal-title":"Noncoding RNA Res"},{"key":"12706_CR24","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/genes11091002","volume":"11","author":"JT-S Chow","year":"2020","unstructured":"Chow JT-S, Salmena L. Prediction and analysis of SARS-CoV-2-Targeting MicroRNA in human lung epithelium. Genes (Basel). 2020;11:1002. https:\/\/doi.org\/10.3390\/genes11091002.","journal-title":"Genes (Basel)"},{"key":"12706_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2021.2010959","volume":"19","author":"SM Akula","year":"2022","unstructured":"Akula SM, Bolin P, Cook PP. Cellular miR-150-5p May have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol. 2022;19:1\u201311. https:\/\/doi.org\/10.1080\/15476286.2021.2010959.","journal-title":"RNA Biol"},{"key":"12706_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.gendis.2020.04.002","volume":"7","author":"L Chen","year":"2020","unstructured":"Chen L, Zhong L. Genomics functional analysis and drug screening of SARS-CoV-2. Genes Dis. 2020;7:542\u201350. https:\/\/doi.org\/10.1016\/j.gendis.2020.04.002.","journal-title":"Genes Dis"},{"key":"12706_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/15476286.2022.2100629","volume":"19","author":"C Eyileten","year":"2022","unstructured":"Eyileten C, Wicik Z, Sim\u00f5es SN, Martins-Jr DC, Klos K, Wlodarczyk W, et al. Thrombosis-related Circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. RNA Biol. 2022;19:963\u201379. https:\/\/doi.org\/10.1080\/15476286.2022.2100629.","journal-title":"RNA Biol"},{"key":"12706_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/15257770.2021.1950759","volume":"40","author":"A Sato","year":"2021","unstructured":"Sato A, Ogino Y, Tanuma S, Uchiumi F. Human MicroRNA hsa-miR-15b-5p targets the RNA template component of the RNA-dependent RNA polymerase structure in severe acute respiratory syndrome coronavirus 2. Nucleosides Nucleotides Nucleic Acids. 2021;40:790\u20137. https:\/\/doi.org\/10.1080\/15257770.2021.1950759.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"12706_CR29","doi-asserted-by":"publisher","unstructured":"Zhu X, Guo Q, Zou J, Wang B, Zhang Z, Wei R, et al. MiR-19a-3p suppresses M1 macrophage polarization by inhibiting STAT1\/IRF1 pathway. Front Pharmacol. 2021;12. https:\/\/doi.org\/10.3389\/fphar.2021.614044.","DOI":"10.3389\/fphar.2021.614044"},{"key":"12706_CR30","doi-asserted-by":"publisher","first-page":"105020","DOI":"10.1016\/j.meegid.2021.105020","volume":"94","author":"M Fayyad-Kazan","year":"2021","unstructured":"Fayyad-Kazan M, Makki R, Skafi N, El Homsi M, Hamade A, El Majzoub R, et al. Circulating mirnas: potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect Genet Evol. 2021;94:105020. https:\/\/doi.org\/10.1016\/j.meegid.2021.105020.","journal-title":"Infect Genet Evol"},{"key":"12706_CR31","doi-asserted-by":"publisher","first-page":"10351","DOI":"10.3390\/ijms221910351","volume":"22","author":"RP Duecker","year":"2021","unstructured":"Duecker RP, Adam EH, Wirtz S, Gronau L, Khodamoradi Y, Eberhardt FJ, et al. The MiR-320 family is strongly downregulated in patients with COVID-19 induced severe respiratory failure. Int J Mol Sci. 2021;22:10351. https:\/\/doi.org\/10.3390\/ijms221910351.","journal-title":"Int J Mol Sci"},{"key":"12706_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/path.5204","volume":"247","author":"B Vanchin","year":"2019","unstructured":"Vanchin B, Offringa E, Friedrich J, Brinker MG, Kiers B, Pereira AC, et al. MicroRNA-374b induces endothelial\u2010to\u2010mesenchymal transition and early lesion formation through the Inhibition of MAPK7 signaling. J Pathol. 2019;247:456\u201370. https:\/\/doi.org\/10.1002\/path.5204.","journal-title":"J Pathol"},{"key":"12706_CR33","doi-asserted-by":"publisher","first-page":"e1009759","DOI":"10.1371\/journal.ppat.1009759","volume":"17","author":"RJ Farr","year":"2021","unstructured":"Farr RJ, Rootes CL, Rowntree LC, Nguyen THO, Hensen L, Kedzierski L, et al. Altered MicroRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 2021;17:e1009759. https:\/\/doi.org\/10.1371\/journal.ppat.1009759.","journal-title":"PLoS Pathog"},{"key":"12706_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s43856-024-00675-9","volume":"5","author":"O Launay","year":"2025","unstructured":"Launay O, Gupta R, Machabert T, Konate E, Rousseau A, Vigne C, et al. Beta-variant Recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variants. Commun Med. 2025;5:21. https:\/\/doi.org\/10.1038\/s43856-024-00675-9.","journal-title":"Commun Med"},{"key":"12706_CR35","doi-asserted-by":"publisher","unstructured":"Mwangi P, Okendo J, Mogotsi M, Ogunbayo A, Adelabu O, Sondlane H, et al. SARS-CoV-2 variants from COVID-19 positive cases in the free state province, South Africa from July 2020 to December 2021. Front Virol. 2022;2. https:\/\/doi.org\/10.3389\/fviro.2022.935131.","DOI":"10.3389\/fviro.2022.935131"},{"key":"12706_CR36","unstructured":"WHO. COVID-19 Variants. WHO, COVID-19 Variants. 2025. 2025. https:\/\/data.who.int\/dashboards\/covid19\/variants. Accessed 18 Feb 2025."},{"key":"12706_CR37","unstructured":"Health VW. A Timeline of COVID-19 Variants Delta variant. 2025. https:\/\/www.verywellhealth.com\/covid-variants-timeline-6741198. Accessed\u00a0 18 Feb 2025."},{"key":"12706_CR38","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/pathogens11080834","volume":"11","author":"WH Roshdy","year":"2022","unstructured":"Roshdy WH, Kandeil A, El-Shesheny R, Khalifa MK, Al-Karmalawy AA, Showky S, et al. Insight into genetic characteristics of identified SARS-CoV-2 variants in Egypt from March 2020 to May 2021. Pathogens. 2022;11:834. https:\/\/doi.org\/10.3390\/pathogens11080834.","journal-title":"Pathogens"},{"key":"12706_CR39","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1091\/mbc.e12-05-0396","volume":"23","author":"Y Wang","year":"2012","unstructured":"Wang Y, Zhang X, Zhang H, Lu Y, Huang H, Dong X, et al. Coiled-coil networking shapes cell molecular machinery. Mol Biol Cell. 2012;23:3911\u201322. https:\/\/doi.org\/10.1091\/mbc.e12-05-0396.","journal-title":"Mol Biol Cell"},{"key":"12706_CR40","doi-asserted-by":"publisher","first-page":"e1000622","DOI":"10.1371\/journal.pbio.1000622","volume":"9","author":"MJ McDonald","year":"2011","unstructured":"McDonald MJ, Wang W-C, Huang H-D, Leu J-Y. Clusters of nucleotide substitutions and Insertion\/Deletion mutations are associated with repeat sequences. PLoS Biol. 2011;9:e1000622. https:\/\/doi.org\/10.1371\/journal.pbio.1000622.","journal-title":"PLoS Biol"},{"key":"12706_CR41","doi-asserted-by":"publisher","first-page":"e82753","DOI":"10.1371\/journal.pone.0082753","volume":"8","author":"I Moret","year":"2013","unstructured":"Moret I, S\u00e1nchez-Izquierdo D, Iborra M, Tortosa L, Navarro-Puche A, Nos P, et al. Assessing an improved protocol for plasma MicroRNA extraction. PLoS ONE. 2013;8:e82753. https:\/\/doi.org\/10.1371\/journal.pone.0082753.","journal-title":"PLoS ONE"},{"key":"12706_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative Real-Time PCR experiments. Clin Chem. 2009;55:611\u201322. https:\/\/doi.org\/10.1373\/clinchem.2008.112797.","journal-title":"Clin Chem"},{"key":"12706_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/14737159.5.2.209","volume":"5","author":"M Arya","year":"2005","unstructured":"Arya M, Shergill IS, Williamson M, Gommersall L, Arya N, Patel HR. Basic principles of real-time quantitative PCR. Expert Rev Mol Diagn. 2005;5:209\u201319. https:\/\/doi.org\/10.1586\/14737159.5.2.209.","journal-title":"Expert Rev Mol Diagn"},{"key":"12706_CR44","doi-asserted-by":"publisher","first-page":"12296","DOI":"10.1021\/jf304690e","volume":"60","author":"H Cao","year":"2012","unstructured":"Cao H, Shockey JM. Comparison of TaqMan and SYBR green qPCR methods for quantitative gene expression in Tung tree tissues. J Agric Food Chem. 2012;60:12296\u2013303. https:\/\/doi.org\/10.1021\/jf304690e.","journal-title":"J Agric Food Chem"},{"key":"12706_CR45","doi-asserted-by":"publisher","first-page":"e23578","DOI":"10.1371\/journal.pone.0023578","volume":"6","author":"S Guillaume","year":"2011","unstructured":"Guillaume S, Jaussent I, Oli\u00e9 E, Genty C, Bringer J, Courtet P, et al. Characteristics of suicide attempts in anorexia and bulimia nervosa: A Case\u2013Control study. PLoS ONE. 2011;6:e23578. https:\/\/doi.org\/10.1371\/journal.pone.0023578.","journal-title":"PLoS ONE"},{"key":"12706_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1039\/D2SD00140C","volume":"2","author":"K Pollet","year":"2023","unstructured":"Pollet K, Garnier N, Szunerits S, Madder A, Hober D, Engelmann I. Host MiRNAs as biomarkers of SARS-CoV-2 infection: a critical review. Sens Diagnostics. 2023;2:12\u201335. https:\/\/doi.org\/10.1039\/D2SD00140C.","journal-title":"Sens Diagnostics"},{"key":"12706_CR47","doi-asserted-by":"publisher","unstructured":"Chakraborty C, Bhattacharya M, Lee S. Regulatory role of MiRNAs in the human immune and inflammatory response during the infection of SARS-CoV\u20102 and other respiratory viruses: a comprehensive review. Rev Med Virol. 2024;34. https:\/\/doi.org\/10.1002\/rmv.2526.","DOI":"10.1002\/rmv.2526"},{"key":"12706_CR48","doi-asserted-by":"publisher","first-page":"112282","DOI":"10.1016\/j.celrep.2023.112282","volume":"42","author":"N Fossat","year":"2023","unstructured":"Fossat N, Lundsgaard EA, Costa R, Rivera-Rangel LR, Nielsen L, Mikkelsen LS, et al. Identification of the viral and cellular MicroRNA interactomes during SARS-CoV-2 infection. Cell Rep. 2023;42:112282. https:\/\/doi.org\/10.1016\/j.celrep.2023.112282.","journal-title":"Cell Rep"},{"key":"12706_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/ncrna10060062","volume":"10","author":"GA Calin","year":"2024","unstructured":"Calin GA, Hub\u00e9 F, Ladomery MR, Delihas N, Ferracin M, Poliseno L, et al. The 2024 nobel prize in physiology or medicine: MicroRNA takes center stage. Noncoding RNA. 2024;10:62. https:\/\/doi.org\/10.3390\/ncrna10060062.","journal-title":"Noncoding RNA"},{"key":"12706_CR50","doi-asserted-by":"publisher","first-page":"131926","DOI":"10.1016\/j.ijbiomac.2024.131926","volume":"269","author":"T Belmonte","year":"2024","unstructured":"Belmonte T, Perez-Pons M, Ben\u00edtez ID, Molinero M, Garc\u00eda-Hidalgo MC, Rodr\u00edguez-Mu\u00f1oz C, et al. Addressing the unsolved challenges in microRNA-based biomarker development: suitable endogenous reference MicroRNAs for SARS-CoV-2 infection severity. Int J Biol Macromol. 2024;269:131926. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131926.","journal-title":"Int J Biol Macromol"},{"key":"12706_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7150\/thno.78164","volume":"13","author":"Y Liang","year":"2023","unstructured":"Liang Y, Fang D, Gao X, Deng X, Chen N, Wu J, et al. Circulating MicroRNAs as emerging regulators of COVID-19. Theranostics. 2023;13:125\u201347. https:\/\/doi.org\/10.7150\/thno.78164.","journal-title":"Theranostics"},{"key":"12706_CR52","doi-asserted-by":"publisher","first-page":"102118","DOI":"10.1016\/j.omtn.2024.102118","volume":"35","author":"M Perez-Pons","year":"2024","unstructured":"Perez-Pons M, Molinero M, Ben\u00edtez ID, Garc\u00eda-Hidalgo MC, Chatterjee S, B\u00e4r C, et al. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19. Mol Ther Nucleic Acids. 2024;35:102118. https:\/\/doi.org\/10.1016\/j.omtn.2024.102118.","journal-title":"Mol Ther Nucleic Acids"},{"key":"12706_CR53","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41392-023-01669-0","volume":"8","author":"X Liu","year":"2023","unstructured":"Liu X, Xiong W, Ye M, Lu T, Yuan K, Chang S, et al. Non-coding RNAs expression in SARS-CoV-2 infection: Pathogenesis, clinical significance and therapeutic targets. Signal Transduct Target Ther. 2023;8:441. https:\/\/doi.org\/10.1038\/s41392-023-01669-0.","journal-title":"Signal Transduct Target Ther"},{"key":"12706_CR54","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1093\/cvr\/cvab327","volume":"118","author":"M Vanhaverbeke","year":"2022","unstructured":"Vanhaverbeke M, Attard R, Bartekova M, Ben-Aicha S, Brandenburger T, de Gonzalo-Calvo D, et al. Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129. Cardiovasc Res. 2022;118:3183\u201397. https:\/\/doi.org\/10.1093\/cvr\/cvab327.","journal-title":"Cardiovasc Res"},{"key":"12706_CR55","doi-asserted-by":"publisher","first-page":"953","DOI":"10.14348\/molcells.2020.0177","volume":"43","author":"WR Kim","year":"2020","unstructured":"Kim WR, Park EG, Kang K-W, Lee S-M, Kim B, Kim H-S. Expression analyses of MicroRNAs in hamster lung tissues infected by SARS-CoV-2. Mol Cells. 2020;43:953\u201363. https:\/\/doi.org\/10.14348\/molcells.2020.0177.","journal-title":"Mol Cells"},{"key":"12706_CR56","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.mlwa.2021.100150","volume":"6","author":"LA Bugnon","year":"2021","unstructured":"Bugnon LA, Raad J, Merino GA, Yones C, Ariel F, Milone DH, et al. Deep learning for the discovery of new pre-miRNAs: helping the fight against COVID-19. Mach Learn Appl. 2021;6:100150. https:\/\/doi.org\/10.1016\/j.mlwa.2021.100150.","journal-title":"Mach Learn Appl"},{"key":"12706_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3892\/ijmm.2021.5075","volume":"49","author":"P Katopodis","year":"2021","unstructured":"Katopodis P, Randeva HS, Spandidos DA, Saravi S, Kyrou I, Karteris E. Host cell entry mediators implicated in the cellular tropism of SARS-CoV-2, the pathophysiology of COVID-19 and the identification of MicroRNAs that can modulate the expression of these mediators (Review). Int J Mol Med. 2021;49:20. https:\/\/doi.org\/10.3892\/ijmm.2021.5075.","journal-title":"Int J Mol Med"},{"key":"12706_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/15384101.2020.1867792","volume":"20","author":"F Abedi","year":"2021","unstructured":"Abedi F, Rezaee R, Hayes AW, Nasiripour S, Karimi G. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? Cell Cycle. 2021;20:143\u201353. https:\/\/doi.org\/10.1080\/15384101.2020.1867792.","journal-title":"Cell Cycle"},{"key":"12706_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/cdd.2009.69","volume":"17","author":"RI Aqeilan","year":"2010","unstructured":"Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010;17:215\u201320. https:\/\/doi.org\/10.1038\/cdd.2009.69.","journal-title":"Cell Death Differ"},{"key":"12706_CR60","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-08-4277","volume":"69","author":"N Bandi","year":"2009","unstructured":"Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, et al. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-Dependent manner and are frequently deleted or Down-regulated in Non\u2013Small cell lung cancer. Cancer Res. 2009;69:5553\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4277.","journal-title":"Cancer Res"},{"key":"12706_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/v14010041","volume":"14","author":"B Bautista-Becerril","year":"2021","unstructured":"Bautista-Becerril B, P\u00e9rez-Dimas G, Sommerhalder-Nava PC, Hanono A, Mart\u00ednez-Cisneros JA, Zarate-Maldonado B, et al. miRNAs, from evolutionary junk to possible prognostic markers and therapeutic targets in COVID-19. Viruses. 2021;14:41. https:\/\/doi.org\/10.3390\/v14010041.","journal-title":"Viruses"},{"key":"12706_CR62","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.thromres.2015.07.005","volume":"136","author":"I Starikova","year":"2015","unstructured":"Starikova I, Jamaly S, Sorrentino A, Blondal T, Latysheva N, Sovershaev M, et al. Differential expression of plasma MiRNAs in patients with unprovoked venous thromboembolism and healthy control individuals. Thromb Res. 2015;136:566\u201372. https:\/\/doi.org\/10.1016\/j.thromres.2015.07.005.","journal-title":"Thromb Res"},{"key":"12706_CR63","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.12659\/MSM.906596","volume":"24","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Ma J, Wang Q, Wu F, Ping J, Ming L. Combination of Circulating miRNA-320a\/b and D-Dimer improves diagnostic accuracy in deep vein thrombosis patients. Med Sci Monit. 2018;24:2031\u20137. https:\/\/doi.org\/10.12659\/MSM.906596.","journal-title":"Med Sci Monit"},{"key":"12706_CR64","doi-asserted-by":"publisher","unstructured":"Cai C, Guo Y, You Y, Hu K, Cai F, Xie M, et al. Deep venous thrombosis in COVID-19 patients: a cohort analysis. Clin Appl Thromb Hemost. 2020;26. https:\/\/doi.org\/10.1177\/1076029620982669.","DOI":"10.1177\/1076029620982669"},{"key":"12706_CR65","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/v13081593","volume":"13","author":"C Grehl","year":"2021","unstructured":"Grehl C, Schulthei\u00df C, Hoffmann K, Binder M, Altmann T, Grosse I, et al. Detection of SARS-CoV-2 derived small RNAs and changes in Circulating small RNAs associated with COVID-19. Viruses. 2021;13:1593. https:\/\/doi.org\/10.3390\/v13081593.","journal-title":"Viruses"},{"key":"12706_CR66","doi-asserted-by":"publisher","unstructured":"Ivashchenko A, Rakhmetullina A, Aisina D, MERS-CoV. How MiRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and. 2020. https:\/\/doi.org\/10.21203\/rs.3.rs-16264\/v1","DOI":"10.21203\/rs.3.rs-16264\/v1"},{"key":"12706_CR67","doi-asserted-by":"publisher","first-page":"e9369","DOI":"10.7717\/peerj.9369","volume":"8","author":"MD Sa\u00e7ar Demirci","year":"2020","unstructured":"Sa\u00e7ar Demirci MD, Adan A. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ. 2020;8:e9369. https:\/\/doi.org\/10.7717\/peerj.9369.","journal-title":"PeerJ"},{"key":"12706_CR68","doi-asserted-by":"publisher","first-page":"109905","DOI":"10.1016\/j.intimp.2023.109905","volume":"117","author":"J Yu Myun","year":"2023","unstructured":"Yu Myun J, Hjie, Zhang J, Ran G, He H, Liu Y, Yang X, Hong H. Exosomal miRNAs-mediated macrophage polarization and its potential clinical application. Int Immunopharmacol. 2023;117:109905. https:\/\/doi.org\/10.1016\/j.intimp.2023.109905","journal-title":"Int Immunopharmacol"},{"key":"12706_CR69","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s43141-023-00565-y","volume":"21","author":"RA-H Haroun","year":"2023","unstructured":"Haroun RA-H, Osman WH, Eessa AM. Prognostic significance of serum miR-18a-5p in severe COVID-19 Egyptian patients. J Genetic Eng Biotechnol. 2023;21:114. https:\/\/doi.org\/10.1186\/s43141-023-00565-y.","journal-title":"J Genetic Eng Biotechnol"},{"key":"12706_CR70","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","volume":"26","author":"N Zhang","year":"2019","unstructured":"Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, et al. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with snail and HDAC1\/2. Cell Death Differ. 2019;26:843\u201359. https:\/\/doi.org\/10.1038\/s41418-018-0158-8.","journal-title":"Cell Death Differ"},{"key":"12706_CR71","doi-asserted-by":"publisher","first-page":"152188","DOI":"10.1016\/j.imbio.2022.152188","volume":"227","author":"X Sheng","year":"2022","unstructured":"Sheng X, Yang Y, Liu J, Yu J, Guo Q, Guan W, et al. Down-regulation of miR-18b-5p protects against Splenic hemorrhagic shock by directly targeting HIF-1\u03b1\/iNOS pathway. Immunobiology. 2022;227:152188. https:\/\/doi.org\/10.1016\/j.imbio.2022.152188.","journal-title":"Immunobiology"},{"key":"12706_CR72","doi-asserted-by":"publisher","first-page":"198631","DOI":"10.1016\/j.virusres.2021.198631","volume":"308","author":"S Paul","year":"2022","unstructured":"Paul S, Bravo V\u00e1zquez LA, Reyes-P\u00e9rez PR, Estrada-Meza C, Aponte Alburquerque RA, Pathak S, et al. The role of MicroRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res. 2022;308:198631. https:\/\/doi.org\/10.1016\/j.virusres.2021.198631.","journal-title":"Virus Res"},{"key":"12706_CR73","doi-asserted-by":"publisher","first-page":"e13388","DOI":"10.1016\/j.heliyon.2023.e13388","volume":"9","author":"S Srivastava","year":"2023","unstructured":"Srivastava S, Garg I, Singh Y, Meena R, Ghosh N, Kumari B, et al. Evaluation of altered MiRNA expression pattern to predict COVID-19 severity. Heliyon. 2023;9:e13388. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13388.","journal-title":"Heliyon"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12706-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:18:26Z","timestamp":1781633906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12706-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12706"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12706-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was revised and approved by the ethical committee of the Faculty of Pharmacy, Ain Shams University, number ENREC-ASU-2021-17. The study was conducted in accordance with the Declaration of Helsinki guidelines and regulations. The unidentified blood samples were collected from \u201cAL-Ahrar Teaching Hospital\u201d laboratory residues during the routine checkup, with hospital approval of the study and waiving the patient\u2019s informed consent, as the clinical samples were unidentified, and there was no contact with patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"662"}}